Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares

Business Wire11-08

Shelf utilization inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024 MOUNTAIN VIEW, Calif., November 08, 2024--(BUSINESS WIRE)--Aditxt, Inc. (...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481810143?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-08 21:30","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2481810143","market":"us","top_or_hot":-1,"title":"Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares","media":"Business Wire","content":"<div>\n<p>Shelf utilization inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024\nMOUNTAIN VIEW, Calif., November 08, 2024--(BUSINESS WIRE)--Aditxt, Inc. (...</p>\n\n<a href=\"https://finance.yahoo.com/news/aditxt-provides-equity-line-credit-133000035.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-08 21:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/aditxt-provides-equity-line-credit-133000035.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shelf utilization inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024\nMOUNTAIN VIEW, Calif., November 08, 2024--(BUSINESS WIRE)--Aditxt, Inc. (...</p>\n\n<a href=\"https://finance.yahoo.com/news/aditxt-provides-equity-line-credit-133000035.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADTX","symbol_name":"ADiTx Therapeutics","start_time":0,"source_url":"https://finance.yahoo.com/news/aditxt-provides-equity-line-credit-133000035.html","article_id":"2481810143","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481810143","pubTimestamp":1731072600,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Shelf utilization inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024. MOUNTAIN VIEW, Calif., November 08, 2024----Aditxt, Inc.  , a social innovation platform dedicated to accelerating promising health innovations, today provided an update to its shareholders on the utilization of its Equity Line of Credit  and At-the-Market  facility, as well as its outstanding number of shares.Equity Issuance Update as of End of Day November 7, 2024:. Total number of shares traded since ELOC and ATM Activation: 153,085,471. Total number of shares sold via ELOC and ATM: 11,920,744, representing approximately 8% of total traded shares since the ELOC and ATM initiation. In addition, Aditxt announces that its use of the Shelf registration statement, inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024. This suspension will remain in effect at least until Aditxt, Appili Therapeutics, Inc., and","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ADTX":"ADiTx Therapeutics","BK4585":"ETF&股票定投概念","BK4139":"生物科技","EVFM":"Evofem Biosciences, Inc.","BK4588":"碎股","BK4007":"制药","EQR":"资产住宅公司","BK4584":"避孕概念","WRD":"文远知行","BK4215":"住宅房地产投资信托"},"translate_title":"Aditxt提供有关股权信用额度、ATM使用情况和已发行股票数量的最新信息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EQR":1,"EVFM":1,"WRD":1,"ADTX":0.9},"content_text":"Shelf utilization inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024\nMOUNTAIN VIEW, Calif., November 08, 2024--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (\"Aditxt\" or the \"Company\"), a social innovation platform dedicated to accelerating promising health innovations, today provided an update to its shareholders on the utilization of its Equity Line of Credit (\"ELOC\") and At-the-Market (\"ATM\") facility, as well as its outstanding number of shares.\nEquity Issuance Update as of End of Day November 7, 2024:\n\nTotal number of shares traded since ELOC and ATM Activation: 153,085,471\nTotal number of shares sold via ELOC and ATM: 11,920,744, representing approximately 8% of total traded shares since the ELOC and ATM initiation\nTotal Outstanding Shares: 12,059,043\n\nIn addition, Aditxt announces that its use of the Shelf registration statement, inclusive of the ELOC and ATM, will be suspended during the stale period beginning Monday, November 11, 2024. This suspension will remain in effect at least until Aditxt, Appili Therapeutics, Inc., and Evofem Biosciences, Inc. complete their respective quarterly filings, and Aditxt has filed updated pro-forma financial statements with respect to such proposed acquisitions.\nAditxt is also actively pursuing debt as the primary method of financing to meet the capital requirements for its acquisition strategy, thereby minimizing reliance on equity-based financing. By prioritizing debt, Aditxt intends to limit dilution and continue delivering value to shareholders while positioning the company for growth.\nAditxt remains committed to transparent communication regarding its capital structure and financing strategy to keep stakeholders informed on developments impacting shareholder value.\nDisclaimer\nThe above represents usage of the ELOC and ATM facilities to date, but is not necessarily indicative of future usage. Aditxt can provide no assurance that future usage will be consistent with its usage to date.\nWe cannot guarantee that future financing will be available in sufficient amounts, or on terms acceptable to us, if at all. The terms of any financing may adversely affect the holdings or the rights of our stockholders and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our shares to decline. The sale of additional equity or convertible securities may dilute our existing stockholders. The incurrence of indebtedness would result in increased fixed payment obligations, and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights, and other operating restrictions that could adversely impact our ability to conduct our business.\nAbout Aditxt, Inc.\nAditxt, Inc.® is a social innovation platform dedicated to accelerating promising health innovations. Aditxt’s ecosystem of research institutions, industry partners, and shareholders collaboratively drives their mission to \"Make Promising Innovations Possible Together.\" The innovation platform is the cornerstone of Aditxt’s strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholder’s voice is heard and valued, and empowers collective progress.\nAditxt currently operates two programs focused on immune health and precision health. The Company plans to introduce two additional programs dedicated to public health and women’s health. For these, Aditxt has entered into an Arrangement Agreement with Appili Therapeutics, Inc. (\"Appili\") (TSX: APLI; OTCPink: APLIF), which focuses on infectious diseases, and a Merger Agreement with Evofem Biosciences, Inc. (\"Evofem\") (OTCQB: EVFM). Each program will be designed to function autonomously while collectively advancing Aditxt’s mission of discovering, developing, and deploying innovative health solutions to tackle some of the most urgent health challenges. The closing of each of the transactions with Appili and Evofem is subject to several conditions, including but not limited to approval of the transactions by the respective target shareholders and Aditxt raising sufficient capital to fund its obligations at closing. These obligations include cash payments of approximately $17 million for Appili and $17 million for Evofem, which includes approximately $15.2 million required to satisfy Evofem's senior secured noteholder; should Aditxt fail to secure these funds, Evofem's senior secured noteholder is expected to seek to prevent the closing of the merger with Evofem. No assurance can be provided that all of the conditions to closing will be obtained or satisfied or that either of the transactions will ultimately close.\nFor more information, www.aditxt.com.\nFollow us on:\nLinkedIn: https://www.linkedin.com/company/aditxt Facebook: https://www.facebook.com/aditxtplatform/\nForward-Looking Statements\nCertain statements in this press release constitute \"forward-looking statements\" within the meaning of federal securities laws. Forward-looking statements include statements regarding the Company’s intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ongoing and planned product and business development; the Company’s ability to finance and execute its strategic M&A initiatives; the Company’s ability to obtain the necessary funding and partner to commence clinical trials; the Company’s intellectual property position; the Company’s ability to develop commercial functions; expectations regarding product launch and revenue; the Company’s results of operations, cash needs, spending, financial condition, liquidity, prospects, growth, and strategies; the Company’s ability to raise additional capital; expected usage of the Company’s ELOC and ATM facilities; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as market and other conditions and those risks more fully discussed in the section titled \"Risk Factors\" in Aditxt’s most recent Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company’s other filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20241108903908/en/\nContacts\nAditxt, Inc. Investors:Jeff Ramson, PCG Advisory, Inc.T: 646-863-6893Jramson@pcgadvisory.com Corporate Communications:Mary O’BrienMobrien@aditxt.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481810143"}